Notice of Intent to issue a Sole Source Award for a GentleMACS Octo Dissociator with Heaters
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Centers for Disease Control and Prevention (CDC), specifically the National Center for Immunization and Respiratory Diseases (NCIRD)/Influenza Division (ID), intends to issue a sole source firm fixed price purchase order to Miltenyi Biotec Inc. for 1 GentleMACS Octo Dissociator with heating units and an instrument service plan.
Scope of Requirement
The GentleMACS Octo Dissociator is required for its unique capabilities, including the simultaneous processing of eight biological samples in a fully closed, sterile system with integrated heating and validated programmable protocols. These protocols are already incorporated into the Quality Manual for Microbiological Laboratories (QMML) Standard Operating Procedures (SOPs). The system features proprietary mechanical dissociation architecture, protected by active patents, ensuring reproducible, high-viability single-cell and nuclei preparations across various tissue types without operator-dependent variability. It is also the only system with OEM-developed, tissue-specific programs that do not require additional programming or third-party modification, and it supports required consumable formats (C Tubes and M Tubes) for sterility and traceability. This system is proven compatible with downstream Luminex and single-cell sequencing workflows under current quality and regulatory requirements.
Contract Details
- Type: Sole Source Firm Fixed Price Purchase Order
- Authority: FAR 12.102(a) for commercial supply
- Set-Aside: None specified (sole source)
- Place of Performance: Atlanta, GA, United States
Response Information
This notice of intent is not a request for competitive quotations. However, the government will consider all quotations/responses received within 15 days of the notice issuance. Information submitted will be used solely to determine if a competitive procurement is feasible. Any quotation or response should be emailed to the contract specialist at zvm0@cdc.gov by April 7, 2026.
Contact Information
- Primary: Eugene L. Gutierrez Jr. (zvm0@cdc.gov, 770-488-0192)
- Secondary: Liubov Kriel (vyh1@cdc.gov, 770-488-2856)